<DOC>
	<DOCNO>NCT00018642</DOCNO>
	<brief_summary>The purpose research study determine whether new drug schizophrenia well maintenance treatment standard drug currently prescribe . The new medication call quetiapine compare standard medication call haloperidol decanoate . The study determine quetiapine cause few problem haloperidol side effect stiffness restlessness whether cost VA less treat patient quetiapine . In addition , blood sample collect every three month determine certain chemical blood influence outcome subject ' illness .</brief_summary>
	<brief_title>Quetiapine v Haloperidol Decanoate Long Term Treatment Schizophrenia Schizoaffective Disorder</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Decanoic acid</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Inclusion Criteria 1 . Schizophrenia Schizoaffective Disorder diagnose DSMIV 2 . Between age 1860 . 3 . A candidate maintenance antipsychotic therapy . This mean patient least two documented episode acute schizophrenic illness least two year continue psychotic symptom . Exclusion Criteria 1 . Organic brain disease . 2 . Mental Retardation 3 . Chronic medical illness would make antipsychotic medication inappropriate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2004</verification_date>
	<keyword>quetiapine</keyword>
	<keyword>haloperidol decanoate</keyword>
</DOC>